Profusa, Inc.

Profusa, Inc. (PFSA) is a health technology company operating in the implantable biosensor and continuous physiological monitoring space, with its securities registered on U.S. public markets. The company filed a Form 10-Q with the Securities and Exchange Commission on May 12, 2022, under accession number 0001213900-22-025671, documenting its quarterly financial results and disclosures for the applicable reporting period. Profusa sits within the medical devices and digital health sector, developing tissue-integrated sensors designed for real-time tracking of biochemical markers. The filing represents a routine periodic disclosure under the company's ongoing SEC reporting obligations. Investors and analysts seeking full filing data, ownership records, and deal-level analytics on Profusa and the broader SPAC universe can sign up for complete access at SpacDesk.